Showing results (11-20 of 174) with videos related to
Sort By:
Pageof 18
Nature Reviews. Immunology|January 26, 2010
Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetesBart O Roep, Mark PeakmanFrontiers in Endocrinology|April 29, 2021
Islet-Resident Dendritic Cells and Macrophages in Type 1 Diabetes: In Search of Bigfoot's PrintHenner Zirpel, Bart O RoepCritical Reviews in Immunology|October 9, 2013
Infectious tolerance as candidate therapy for type 1 diabetes: transfer of immunoregulatory properties from human regulatory T cells to other T cells and proinflammatory dendritic cellsFleur S Kleijwegt, Bart O RoepDiabetologia|April 26, 2017
The elusive role of B lymphocytes and islet autoantibodies in (human) type 1 diabetesStef J Bloem, Bart O RoepImmunotherapy|February 26, 2015
Impact of disease heterogeneity on treatment efficacy of immunotherapy in Type 1 diabetes: different shades of grayNicky J C Woittiez, Bart O RoepCurrent Opinion in Endocrinology, Diabetes, and Obesity|June 29, 2021
Breaking and restoring immune tolerance to pancreatic beta-cells in type 1 diabetesNeslihan Erdem, Enrique Montero, Bart O RoepDiabetes, Obesity & Metabolism|September 20, 2018
Islet stress, degradation and autoimmunitySofia Thomaidou, Arnaud Zaldumbide, Bart O RoepNature Reviews. Endocrinology|January 29, 2014
Immune modulation in humans: implications for type 1 diabetes mellitusBart O Roep, Timothy I M TreeAmerican Journal of Therapeutics|November 11, 2005
T-cell assays to determine disease activity and clinical efficacy of immune therapy in type 1 diabetesPieter van de Linde, Bart O RoepFrontiers in Immunology|December 19, 2017
Translating Mechanism of Regulatory Action of Tolerogenic Dendritic Cells to Monitoring Endpoints in Clinical TrialsJessica S Suwandi, Tatjana Nikolic, Bart O RoepPageof 18